Mediolanum Raises Progressive Holding by 10.9% to 161,477 Shares

PGRPGR

Mediolanum International Funds Ltd boosted its Progressive stake by 10.9% in the third quarter, acquiring 15,932 shares to reach 161,477 shares worth $39.5 million. This represents a notable institutional increase against a backdrop of varied fund activity in PGR during the quarter.

1. Mediolanum International Funds Boosts Stake

In its latest SEC filing for the third quarter, Mediolanum International Funds Ltd increased its holding in The Progressive Corporation by 10.9%, purchasing an additional 15,932 shares to bring its total to 161,477. The added shares raised the fund’s position value to approximately $39.5 million by quarter-end, reflecting confidence in Progressive’s underwriting performance and capital returns strategy.

2. Broader Institutional Movements

Several smaller investors also adjusted positions during the same period. Davis Capital Management initiated a new position valued at roughly $25,000, while Atlantic Union Bankshares and Howard Hughes Medical Institute each established stakes of about $33,000–$34,000. Westside Investment Management grew its stake tenfold to 130 shares, and Richardson Financial Services increased its holding nearly nineteen‐fold to 139 shares. Collectively, institutional investors and hedge funds now own over 85% of outstanding shares.

3. Insider Dispositions Trend

Company insiders have been net sellers over the past three months, offloading a total of 13,788 shares valued at about $3 million. Chief Information Officer Jonathan S. Bauer sold 3,105 shares, reducing his position by 10.6%, while Vice President Andrew J. Quigg trimmed his holding by 4%, selling 1,649 shares. Following these sales, insiders collectively own just 0.34% of the company’s equity.

4. Analyst Ratings and Consensus Outlook

Research houses remain mixed on Progressive. Seven analysts maintain a buy recommendation, twelve rate it as hold and three recommend selling, resulting in a consensus ‘Hold’ stance. Price targets issued in recent months range from mid-200s to mid-300s, reflecting diverging views on premium growth and combined ratio trends. The consensus target stands near $255.70, indicating limited upside from current levels.

Sources

DDDD